| pubmed-article:17062888 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17062888 | lifeskim:mentions | umls-concept:C0035820 | lld:lifeskim |
| pubmed-article:17062888 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:17062888 | lifeskim:mentions | umls-concept:C0011923 | lld:lifeskim |
| pubmed-article:17062888 | lifeskim:mentions | umls-concept:C0058698 | lld:lifeskim |
| pubmed-article:17062888 | lifeskim:mentions | umls-concept:C0032005 | lld:lifeskim |
| pubmed-article:17062888 | lifeskim:mentions | umls-concept:C0178601 | lld:lifeskim |
| pubmed-article:17062888 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:17062888 | pubmed:dateCreated | 2006-10-25 | lld:pubmed |
| pubmed-article:17062888 | pubmed:abstractText | Clinically non-functioning pituitary adenomas (NFPAs) can express functional dopamine D2 receptors. Therapy with dopamine (DA) agonists may result in a NFPA size reduction. However, DA agonist-sensitive and -resistant NFPAs are clinically indistinguishable. We have studied the correlation between in vivo imaging of D2 receptors using (123)I-epidepride and the radiological response of NFPA to DA in 18 patients. | lld:pubmed |
| pubmed-article:17062888 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17062888 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17062888 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17062888 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17062888 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17062888 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17062888 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17062888 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17062888 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17062888 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17062888 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17062888 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17062888 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17062888 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17062888 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:17062888 | pubmed:issn | 0804-4643 | lld:pubmed |
| pubmed-article:17062888 | pubmed:author | pubmed-author:de... | lld:pubmed |
| pubmed-article:17062888 | pubmed:author | pubmed-author:KrenningEric... | lld:pubmed |
| pubmed-article:17062888 | pubmed:author | pubmed-author:KwekkeboomDik... | lld:pubmed |
| pubmed-article:17062888 | pubmed:author | pubmed-author:FeeldersRicha... | lld:pubmed |
| pubmed-article:17062888 | pubmed:author | pubmed-author:van der... | lld:pubmed |
| pubmed-article:17062888 | pubmed:author | pubmed-author:ReijsAmbroos... | lld:pubmed |
| pubmed-article:17062888 | pubmed:author | pubmed-author:van... | lld:pubmed |
| pubmed-article:17062888 | pubmed:author | pubmed-author:TangheHervé... | lld:pubmed |
| pubmed-article:17062888 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17062888 | pubmed:volume | 155 | lld:pubmed |
| pubmed-article:17062888 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17062888 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17062888 | pubmed:pagination | 717-23 | lld:pubmed |
| pubmed-article:17062888 | pubmed:meshHeading | pubmed-meshheading:17062888... | lld:pubmed |
| pubmed-article:17062888 | pubmed:meshHeading | pubmed-meshheading:17062888... | lld:pubmed |
| pubmed-article:17062888 | pubmed:meshHeading | pubmed-meshheading:17062888... | lld:pubmed |
| pubmed-article:17062888 | pubmed:meshHeading | pubmed-meshheading:17062888... | lld:pubmed |
| pubmed-article:17062888 | pubmed:meshHeading | pubmed-meshheading:17062888... | lld:pubmed |
| pubmed-article:17062888 | pubmed:meshHeading | pubmed-meshheading:17062888... | lld:pubmed |
| pubmed-article:17062888 | pubmed:meshHeading | pubmed-meshheading:17062888... | lld:pubmed |
| pubmed-article:17062888 | pubmed:meshHeading | pubmed-meshheading:17062888... | lld:pubmed |
| pubmed-article:17062888 | pubmed:meshHeading | pubmed-meshheading:17062888... | lld:pubmed |
| pubmed-article:17062888 | pubmed:meshHeading | pubmed-meshheading:17062888... | lld:pubmed |
| pubmed-article:17062888 | pubmed:meshHeading | pubmed-meshheading:17062888... | lld:pubmed |
| pubmed-article:17062888 | pubmed:meshHeading | pubmed-meshheading:17062888... | lld:pubmed |
| pubmed-article:17062888 | pubmed:meshHeading | pubmed-meshheading:17062888... | lld:pubmed |
| pubmed-article:17062888 | pubmed:meshHeading | pubmed-meshheading:17062888... | lld:pubmed |
| pubmed-article:17062888 | pubmed:meshHeading | pubmed-meshheading:17062888... | lld:pubmed |
| pubmed-article:17062888 | pubmed:meshHeading | pubmed-meshheading:17062888... | lld:pubmed |
| pubmed-article:17062888 | pubmed:meshHeading | pubmed-meshheading:17062888... | lld:pubmed |
| pubmed-article:17062888 | pubmed:meshHeading | pubmed-meshheading:17062888... | lld:pubmed |
| pubmed-article:17062888 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:17062888 | pubmed:articleTitle | Dopamine agonist therapy of clinically non-functioning pituitary macroadenomas. Is there a role for 123I-epidepride dopamine D2 receptor imaging? | lld:pubmed |
| pubmed-article:17062888 | pubmed:affiliation | Department of Internal Medicine, Section of Endocrinology, Erasmus MC, S Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands. w.w.deherder@erasmusmc.nl | lld:pubmed |
| pubmed-article:17062888 | pubmed:publicationType | Journal Article | lld:pubmed |
